ES366173A1 - Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo. - Google Patents

Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo.

Info

Publication number: ES366173A1
Authority: ES; Spain
Prior art keywords: antacid; composition; viscosity; gelation agent; gelation
Prior art date: 1968-04-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES366173A

Other languages

English (en)

Spanish (es)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1968-04-18

Filing date

1969-04-17

Publication date

1971-04-01

1969-04-17 Application filed by Individual filed Critical Individual

1971-04-01 Publication of ES366173A1 publication Critical patent/ES366173A1/es

Status Expired legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title abstract 8
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title abstract 6
229940069428 antacid Drugs 0.000 title abstract 6
239000003159 antacid agent Substances 0.000 title abstract 6
230000001458 anti-acid effect Effects 0.000 title abstract 6
239000003795 chemical substances by application Substances 0.000 abstract 5
238000001879 gelation Methods 0.000 abstract 5
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
229910019142 PO4 Inorganic materials 0.000 abstract 2
239000007900 aqueous suspension Substances 0.000 abstract 2
239000012530 fluid Substances 0.000 abstract 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
239000010452 phosphate Substances 0.000 abstract 2
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
229910020335 Na3 PO4.12H2 O Inorganic materials 0.000 abstract 1
JPKKQJKQTPNWTR-KQAYXBCTSA-N [(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2r)-3-hydroxy-2-phenylpropanoate;sulfuric acid;hydrate Chemical compound O.OS(O)(=O)=O.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1.C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 JPKKQJKQTPNWTR-KQAYXBCTSA-N 0.000 abstract 1
229940124326 anaesthetic agent Drugs 0.000 abstract 1
230000003444 anaesthetic effect Effects 0.000 abstract 1
125000000129 anionic group Chemical group 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
230000002921 anti-spasmodic effect Effects 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
229940124575 antispasmodic agent Drugs 0.000 abstract 1
GUBNMFJOJGDCEL-UHFFFAOYSA-N dicyclomine hydrochloride Chemical compound [Cl-].C1CCCCC1C1(C(=O)OCC[NH+](CC)CC)CCCCC1 GUBNMFJOJGDCEL-UHFFFAOYSA-N 0.000 abstract 1
229940110321 dicyclomine hydrochloride Drugs 0.000 abstract 1
238000007865 diluting Methods 0.000 abstract 1
239000012153 distilled water Substances 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
150000002772 monosaccharides Chemical class 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
230000000750 progressive effect Effects 0.000 abstract 1
229940125723 sedative agent Drugs 0.000 abstract 1
239000000932 sedative agent Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
229940072358 xylocaine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

ES366173A 1968-04-18 1969-04-17 Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo. Expired ES366173A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72217668A	1968-04-18	1968-04-18
US78572768A	1968-12-20	1968-12-20

Publications (1)

Publication Number	Publication Date
ES366173A1 true ES366173A1 (es)	1971-04-01

Family

ID=27110553

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES366173A Expired ES366173A1 (es)	1968-04-18	1969-04-17	Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo.

Country Status (15)

Country	Link
JP (1)	JPS4621672B1 (mo)
AU (1)	AU438147B2 (mo)
BE (1)	BE731695A (mo)
CA (1)	CA959760A (mo)
CH (1)	CH536114A (mo)
DE (1)	DE1919802A1 (mo)
DK (1)	DK127269B (mo)
ES (1)	ES366173A1 (mo)
FI (1)	FI50831C (mo)
FR (1)	FR2007475A1 (mo)
GB (1)	GB1269987A (mo)
IL (1)	IL32020A (mo)
NL (1)	NL6906087A (mo)
NO (1)	NO129077B (mo)
SE (1)	SE388356B (mo)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1401256A (en) *	1972-06-30	1975-07-16	Miles Lab	Anticid tablet and preparation thereof
GB1601833A (en) *	1978-02-06	1981-11-04	Wellcome Found	Antacid formulation
SE7905972L (sv) *	1979-07-09	1981-01-10	Haessle Ab	Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
WO1986005981A1 (en) *	1985-04-18	1986-10-23	Borody Thomas J	Treatment of non-ulcer dyspepsia with bismuth salts
IT1215332B (it) *	1987-01-12	1990-02-08	Crinos Industria Farmaco	Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3812378A1 (de) *	1988-04-14	1989-10-26	Theo Mertens	Mobile erntegutmahl- und -mischvorrichtung
US4988679A (en) *	1989-01-03	1991-01-29	Leonard Chavkin	Liquid sustained release composition
US4980175A (en) *	1989-01-03	1990-12-25	Leonard Chavkin	Liquid orally administrable compositions based on edible oils
DE4305919A1 (de) *	1993-02-26	1994-09-01	Ruediger Potthoff	Transportsilo für Kunststoff-Granulat
US7135197B2 (en)	2002-02-04	2006-11-14	Pharmacia Corporation	Stable pharmaceutical composition useful for treating gastrointestinal disorders
WO2003074086A1 (fr) *	2002-03-04	2003-09-12	Medrx Co., Ltd.	Matrice liquide a transfert de phase in vivo, et preparations liquides orales
US20030232092A1 (en) *	2002-06-14	2003-12-18	Hasenmayer Donald L.	Liquid antacid compositions
RU2694530C2 (ru)	2014-04-29	2019-07-16	Дзе Проктер Энд Гэмбл Компани	Способ изготовления жидких фармацевтических суспензий, содержащих висмут
RU2676261C2 (ru)	2014-04-29	2018-12-27	Дзе Проктер Энд Гэмбл Компани	Жидкие фармацевтические суспензии, содержащие висмут
CN114732828A (zh) *	2022-04-27	2022-07-12	广西南宁百会药业集团有限公司	一种铝碳酸镁混悬液及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE621147A (mo) *

1969
- 1969-04-14 GB GB09070/69A patent/GB1269987A/en not_active Expired
- 1969-04-14 IL IL32020A patent/IL32020A/en unknown
- 1969-04-15 FI FI691089A patent/FI50831C/fi active
- 1969-04-15 NO NO1526/69A patent/NO129077B/no unknown
- 1969-04-16 CA CA048,813A patent/CA959760A/en not_active Expired
- 1969-04-16 AU AU53539/69A patent/AU438147B2/en not_active Expired
- 1969-04-17 DK DK209369AA patent/DK127269B/da unknown
- 1969-04-17 ES ES366173A patent/ES366173A1/es not_active Expired
- 1969-04-18 SE SE6905549A patent/SE388356B/xx unknown
- 1969-04-18 FR FR6912182A patent/FR2007475A1/fr not_active Withdrawn
- 1969-04-18 JP JP3015469A patent/JPS4621672B1/ja active Pending
- 1969-04-18 NL NL6906087A patent/NL6906087A/xx unknown
- 1969-04-18 CH CH593269A patent/CH536114A/fr not_active IP Right Cessation
- 1969-04-18 DE DE19691919802 patent/DE1919802A1/de not_active Ceased
- 1969-04-18 BE BE731695D patent/BE731695A/xx unknown

Also Published As

Publication number	Publication date
NL6906087A (mo)	1969-10-21
AU5353969A (en)	1970-10-22
IL32020A0 (en)	1969-06-25
CA959760A (en)	1974-12-24
AU438147B2 (en)	1973-07-18
DK127269B (da)	1973-10-15
SE388356B (sv)	1976-10-04
FR2007475A1 (mo)	1970-01-09
IL32020A (en)	1972-11-28
JPS4621672B1 (mo)	1971-06-19
FI50831C (fi)	1976-08-10
NO129077B (mo)	1974-02-25
BE731695A (mo)	1969-10-20
FI50831B (mo)	1976-04-30
CH536114A (fr)	1973-04-30
DE1919802A1 (de)	1969-11-06
GB1269987A (en)	1972-04-12

Publication	Publication Date	Title
GB1269987A (en)	1972-04-12	Antacid composition
US3740421A (en)	1973-06-19	Polyoxyethylene-polyoxypropylene aqueous gels
GB1340516A (en)	1973-12-12	Ophthalmic solution
AU697767B2 (en)	1998-10-15	Topically applicable pharmaceutical composition, process of manufacture, and use of the composition
US3171752A (en)	1965-03-02	Contact lens treating solution
US2550622A (en)	1951-04-24	Ointment base and iodine ointment
KR950700072A (ko)	1995-01-16	클린다마이신과 벤조일 페록사이드를 함유한 좌창 치료용 조성물(Composi-tions of clindamycin and benzoyl peroxide for acne treatment)
ES439113A1 (es)	1977-10-16	Procedimiento para preparar productos farmaceuticos de pene-tracion a traves de la piel.
CN101524363A (zh)	2009-09-09	一种人工唾液
DE69401502D1 (de)	1997-02-27	Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält
GB1188396A (en)	1970-04-15	Treatment of Radioactive Liquids
GB1325268A (en)	1973-08-01	Oxymethylene polymer -silica compositions
GB1151476A (en)	1969-05-07	An Agent for Increasing the Stability of Beer
DE3866198D1 (de)	1991-12-19	Pharmazeutische zubereitung fuer die intrarektale verabreichung von calcitonin und daraus hergestellte einzeldosisformen.
JPH05505405A (ja)	1993-08-12	アメトカインを含有する医薬組成物
US2738300A (en)	1956-03-13	Stable aqueous penicillin preparation
US2798816A (en)	1957-07-09	Permanently sterilized dental material
JP3105302B2 (ja)	2000-10-30	クリーム基剤
GB1132576A (en)	1968-11-06	X-ray contrast media
GB903565A (en)	1962-08-15	Organopolysiloxane compositions having anti-foaming properties
ES396666A1 (es)	1974-12-16	Mejoras introducidas en un metodo para la preparacion de una pasta dentifrica.
US2115848A (en)	1938-05-03	Ephedrine composition
US2511740A (en)	1950-06-13	Stabilized thixotrpic gels
US915977A (en)	1909-03-23	Process of obtaining strong aqueous solutions of creosote.
AT287919B (de)	1971-02-10	Verfahren zur Herstellung von injektionslösungen von therapeutisch wertvollen Benzodiazepinderivaten